Adopted Trials - Breast
Acronym: BRCA
Full Title
A randomised phase II pilot trial of carboplatin compared to docetaxel for patients with metastatic genetic breast cancer.
Treatment: Chemotherapy
Phase: 2
Current status: Closed to recruitment - in follow-up
Chief Investigator: Dr Andrew Tutt
Type of trial: Early Phase
Acronym: PRIME II
Full Title
A randomised breast cancer trial to assess local control in older patients
Treatment: Radiotherapy
Phase: 2
Current status: Open to recruitment
Chief Investigator: Dr Ian Kunkler
Type of trial: Early Phase
Website: http://homepages.ed.ac.uk/prime/
Acronym: CA163-115
Full Title
A phase II open label, randomised, 3 arm trial of 2 schedules of Ixabepilon Plus Bevacizumab and Paclitaxel Plus Bevecizumab as first line therapy for locally recurrent metastatic breast cancer
Treatment: Other (please specify in Notes)
Phase: 2
Current status: Completed and closed down
Chief Investigator: Dr Mark Verrill
Type of trial: Early Phase
Acronym: Syndax
Full Title
A Phase 2, Multicenter, Study of the Effect of the Addition of SNDX-275 to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women with ER+ Breast Cancer Whose Disease is Progressing
Treatment: Chemotherapy
Phase: 2
Current status: Closed to recruitment - in follow-up
Chief Investigator: Dr Andrew Wardley
Type of trial: Early Phase
Website:
Acronym: FORUM
Full Title
Partial Breast Irradiation: a Phase II Multi Centre Feasibility Study Utilising Mammosite Brachytherapy
Treatment: Radiotherapy
Phase: 2
Current status: Open to recruitment
Chief Investigator: Dr Zafar Malik
Type of trial: New Technologies
Website:
